Mapping candidate non-MHC susceptibility regions to multiple sclerosis

Genes and Immunity

Volumn 7, Issue 6, 2006, Pages 494-502

  Abdeen, H ^a   Heggarty, S ^b   Hawkins, S A ^b,c   Hutchinson, M ^d   McDonnell, G V ^c   Graham, C A ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 20P; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; IRELAND; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MICROSATELLITE REPEATS; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

EID: 33748308913     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364320     Document Type: Article

References (50)

1. Jersild C, Svejgaard A, Fog T. HLA antigens and multiple sclerosis. Lancet 1972; 2: 1240-1241.
2. Haines J, Pericak-Vance M, Seboun E, Hauser S, the Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 1996; 13: 469-471.
3. Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, et al. (American-French Multiple Sclerosis Genetics Group). A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 2004; 75 (6): 1070-1078.
4. Ban M, Stewart GJ, Bennetts BH, Heard R, Simmons R, Maranian M et al. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun 2002; 3: 464-469.
5. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13: 464-468.
6. Hensiek AE, Roxburgh R, Smilie B, Coraddu F, Akesson E, Holmans P et al. Updated results of the United Kingdom linkage-based genome screen in multiple sclerosis. J Neuroimmunol 2003; 143: 25-30.
7. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C et al. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472-476.
8. Dyment DA, Sadovnick AD, Willer CJ, Armstrong H, Cader ZM, Wiltshire S, et al. (Canadian Collaborative Study Group). An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: A report from the Canadian Collaborative Study Group. Hum Mol Genet 2004; 13 (10): 1005-1015.
9. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ et al. Genome wide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61 (6): 1379-1387.
10. Broadley S, Sawcer S, D'Alfonso S, Hensiek A, Coraddu F, Gray J et al. A genome screen for multiple sclerosis in Italian families. Gene Immun 2001; 4: 205-210.
11. Coraddu F, Sawcer S, D'Alfonso S, Lai M, Hensiek A, Solla E et al. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet 2001; 19: 621-626.
12. Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun 2002; 3: 279-285.
13. Eraksoy M, Kurtuncu M, Akman-Demir G, Kilinc M, Gedizlioglu M, Mirza M, et al. (Turkish Multiple Sclerosis Genetics Study Group). A whole genome screen for linkage in Turkish multiple sclerosis. J Neuroimmunol 2003; 143: 17-24.
14. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, et al. (for The International Multiple Sclerosis Genetics Consortium). A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-467.
15. The Genetic Analysis of Multiple sclerosis in EuropeanS. GAMES. J Neuroimmunol 2003; 143: 1-140.
16. GAMES. Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 2003; 143 (1-2): 39-46.
17. Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE. Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis. J Neuroimmunol 2005; 167 (1-2): 57-169.
18. Suh Y, Vijg J. SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res 2005; 573 (1-2): 41-53.
19. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: Design and analysis issues. Mutat Res 2005; 573 (1-2): 54-69.
20. Haines JL, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA, et al., (Multiple Sclerosis Genetics Group). Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet 2002; 11 (19): 2251-2256.
21. Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF et al. Investigation of seven proposed regions of linkage in multiple sclerosis: An American and French collaborative study. Neurogenetics 2004; 5 (1): 45-48.
22. Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL et al. Examination of seven candidate regions for multiple sclerosis: Strong evidence of linkage to chromosome 1q44. Genes Immun 2006; 7 (1): 73-76.
23. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M et al. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121 (Part 10): 1869-1887.
24. Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J et al. Genetic susceptibility to MS: A second stage analysis in Canadian MS families. Neurogenetics 2001; 3 (3): 145-151.
25. D'Alfonso S, Nistico L, Zavattari P, Marrosu MG, Murru R, Lai M et al. Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet 1999; 7 (3): 377-385.
26. Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A et al. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 2002; 125 (Part 6): 1337-1347.
27. Poser CM, Paty DW, Scheinberg L, Mcdonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
28. Mcdonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50 (1): 121-127.
29. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59: 97-105.
30. Heggarty S, Sawcer S, Hawkins S, McDonnell G, Droogan A, Vandenbroeck K et al. A genome wide scan for association with multiple sclerosis in a N. Irish case control population. J Neuroimmunol 2003; 143 (1-2): 93-96.
31. Villoslada P, Barcellos LF, Oksenberg JR. Chromosome 7q21-22 and multiple sclerosis. J Neuroimmunol 2004; 150 (1-2): 1-2.
32. Tishkoff SA, Verrelli BC. Role of evolutionary history on haplotype block structure in the human genome: Implications for disease mapping. Curr Opin Genet Dev 2003; 13 (6): 569-575.
33. Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: Leaving no stone unturned. Genes Immun 2005; 6 (5): 375-387.
34. McGuigan C, Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E et al. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. J Neurol 2005; 252 (10): 1245-1248.
35. Barcellos LF, Thomson G. Genetic analysis of multiple sclerosis in Europeans. J Neuroimmunol 2003; 143 (1-2): 1-6.
36. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112.
37. Godde R, Rohde K, Becker C, Toliat MR, Entz P, Suk A et al. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using > 10,000 SNPs on DNA chips. J Mol Med 2005; 83 (6): 486-494.
38. Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S et al. Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun 2000; 1 (7): 456-459.
39. Saarela J, Schoenberg Fejzo M, Chen D, Finnila S, Parkkonen M, Kuokkanen S et al. Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum Mol Genet 2002; 11 (19): 2257-2267.
40. Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR et al. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics 2001; 3 (4): 195-201.
41. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: The shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005; 7 (23): 1-15.
42. McDonnell GV, Kirk CW, Middleton D, Droogan AG, Hawkins SA, Patterson CC et al. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis. J Neurol 1999; 246 (11): 1051-1058.
43. Ramer MS, Priestley JV, McMahon SB. Functional regeneration of sensory axons into the adult spinal cord. Nature 2000; 403: 312-316.
44. Criswell LA, Pfeiffer K A, Lum RF, Gonzales B, Novitzke J, Kern M et al. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561-571.
45. Falk J, Bonnon C, Girault JA, Faivre-Sarrailh C. F3/contactin. A neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 2002; 94 (6): 327-334.
46. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susaria S et al. Nicotinic acetylcholine receptor alpha-7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
47. Li W, Lee J, Vikis HG, Lee SH, Liu G, Aurandt J et al. Activation of FAK and Src are receptor-proximal events required for netrin signaling. Nat Neurosci 2004; 7: 1213-1221.
48. Ronn LC, Berezin V, Bock E. The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci 2000; 18 (2-3): 193-199.
49. McFarlane S. Metalloproteases: Carving out a role in axon guidance. Neuron 2003; 37 (4): 559-562.
50. Carim-Todd L, Escarceller M, Estivill X, Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur J Neurosci 2003; 18 (12): 3167-3182.